AR078257A2 - COMPOSITION TO IMMUNIZE MAMMALS AGAINST THE AFTOSA VIRUS - Google Patents
COMPOSITION TO IMMUNIZE MAMMALS AGAINST THE AFTOSA VIRUSInfo
- Publication number
- AR078257A2 AR078257A2 ARP100103213A AR078257A2 AR 078257 A2 AR078257 A2 AR 078257A2 AR P100103213 A ARP100103213 A AR P100103213A AR 078257 A2 AR078257 A2 AR 078257A2
- Authority
- AR
- Argentina
- Prior art keywords
- dna sequence
- composition according
- fragment
- sequence encoding
- transgenic plant
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Reivindicacion 1: Una composicion para inmunizar mamíferos contra el virus de la aftosa, caracterizada porque comprende al menos una planta transgénica o una parte de una planta transgénica que expresa cápsides vacías del virus de la aftosa, donde dicha planta transgénica o parte de .la misma comprende en su genoma una construccion de ADN que comprende al menos una secuencia de ADN que codifica a la poliproteína precursora P1 unida a una secuencia de ADN que codifica a la proteasa autocatalítica 2A. Reivindicacion 2: La composicion de acuerdo con la reivindicacion 1, caracterizada porque la construccion de ADN comprende además un fragmento de una secuencia de ADN que codifica un fragmento de la proteína 2B unida a una secuencia de ADN que codifica a la proteasa 3C unida a un fragmento de la secuencia de ADN que codifica a un fragmento de la proteína 3D. Reivindicacion 4: La composicion de acuerdo con la reivindicacion 3, caracterizada porque dicha vacuna es seleccionadas del conjunto comprendido por vacunas parenterales, no-parenterales y comestibles. Reivindicacion 8: La composicion de acuerdo con la reivindicacion 7, caracterizada porque la planta transgénica es una planta de alfalfa. Reivindicacion 9: La composicion de acuerdo con la reivindicacion 1, caracterizada porque comprende al menos un adyuvante y/o excipiente farmacéuticamente aceptable.Claim 1: A composition for immunizing mammals against the foot and mouth disease virus, characterized in that it comprises at least one transgenic plant or a part of a transgenic plant that expresses empty capsids of the foot and mouth disease virus, wherein said transgenic plant or part thereof. It comprises in its genome a DNA construct comprising at least one DNA sequence encoding the precursor polyprotein P1 linked to a DNA sequence encoding the autocatalytic protease 2A. Claim 2: The composition according to claim 1, characterized in that the DNA construct further comprises a fragment of a DNA sequence encoding a fragment of the 2B protein linked to a DNA sequence encoding the 3C protease bound to a DNA sequence fragment that encodes a 3D protein fragment. Claim 4: The composition according to claim 3, characterized in that said vaccine is selected from the set comprising parenteral, non-parenteral and edible vaccines. Claim 8: The composition according to claim 7, characterized in that the transgenic plant is an alfalfa plant. Claim 9: The composition according to claim 1, characterized in that it comprises at least one pharmaceutically acceptable adjuvant and / or excipient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP100103213 AR078257A2 (en) | 2010-09-01 | 2010-09-01 | COMPOSITION TO IMMUNIZE MAMMALS AGAINST THE AFTOSA VIRUS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP100103213 AR078257A2 (en) | 2010-09-01 | 2010-09-01 | COMPOSITION TO IMMUNIZE MAMMALS AGAINST THE AFTOSA VIRUS |
Publications (1)
Publication Number | Publication Date |
---|---|
AR078257A2 true AR078257A2 (en) | 2011-10-26 |
Family
ID=45116469
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP100103213 AR078257A2 (en) | 2010-09-01 | 2010-09-01 | COMPOSITION TO IMMUNIZE MAMMALS AGAINST THE AFTOSA VIRUS |
Country Status (1)
Country | Link |
---|---|
AR (1) | AR078257A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014036645A1 (en) | 2012-09-05 | 2014-03-13 | Medicago Inc. | Picornavirus-like particle production in plants |
-
2010
- 2010-09-01 AR ARP100103213 patent/AR078257A2/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014036645A1 (en) | 2012-09-05 | 2014-03-13 | Medicago Inc. | Picornavirus-like particle production in plants |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2017530124A5 (en) | ||
WO2011112945A3 (en) | Foot and mouth disease virus recombinant vaccines and uses thereof | |
EP2601969A3 (en) | Norovirus vaccine formulations | |
MX2013004159A (en) | Norovirus capsid and rotavirus vp6 protein for use as combined vaccine. | |
RU2014143531A (en) | PCSK9 vaccine | |
UY30385A1 (en) | RECOMBINANT VACCINE AGAINST THE BLUE LANGUAGE VIRUS | |
EP2498814A4 (en) | Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom | |
Zhang et al. | Research in advance for FMD novel vaccines | |
JP2016539946A5 (en) | ||
IL276210B2 (en) | Mers-cov vaccine | |
AR089578A1 (en) | COMPOSITIONS, METHODS TO TREAT HEPATITIS C VIRUS AND PREPARATION PROCESS | |
MA32819B1 (en) | VACCINE COMBINALLY COMBINED AGAINST ACELLULAR POULTRY | |
CL2012000447A1 (en) | Composition or vaccine comprising a recombinant avian paramyxovirus 8 (apmv-8) viral vector; method of producing said vector; and use to prepare medicament useful for inducing an immune response. | |
WO2006115843A3 (en) | Nipah virus vaccines | |
JP2017502662A5 (en) | ||
BRPI1007721B1 (en) | vaccine composition for use in inducing an immune response against a rotavirus in an individual, a rotavirus strain isolated from cdc-9 and a rotavirus strain isolated from cdc-66 | |
PH12019500592A1 (en) | New swine influenza vaccine | |
JP2017526689A5 (en) | ||
UY31285A1 (en) | VACCINES | |
Golde et al. | Evidence of activation and suppression during the early immune response to foot‐and‐mouth disease virus | |
MX2020012913A (en) | Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom. | |
FI3244920T3 (en) | Foot-and-mouth disease vaccine | |
WO2011007339A3 (en) | Chimeric foot and mouth disease viruses | |
EP2329845A4 (en) | Avian influenza virus antigen, and booster immunization method for avian influenza vaccine in combination with mucosal adjuvant which is effective through oral administration | |
AR078257A2 (en) | COMPOSITION TO IMMUNIZE MAMMALS AGAINST THE AFTOSA VIRUS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |